Translational Bridge Studies Leading to a Phase I Clinical Trial of 111In-NLS-Trastuzumab for Auger Electron Radioimmunotherapy of HER2-Positive Breast Cancer Grant uri icon

  •  
  • Overview
  •  
  • Affiliation
  •  
  • View All
  •  

date/time interval

  • July 1, 2014 - June 30, 2020

total award amount

  • CAD 445790